Venning Life Sciences

Venning is a generative biology company focused on the design and development of novel protein therapeutics using advanced artificial intelligence. The company integrates large-scale machine learning models with high-throughput experimental workflows to engineer proteins with optimized therapeutic properties. By bridging the gap between computational prediction and biological reality, Venning aims to accelerate the discovery of biologics for complex diseases. Their platform is designed to improve the precision and speed of protein engineering, moving beyond traditional trial-and-error methods. Founded by experts from the Wyss Institute at Harvard, the company leverages proprietary datasets to train models specifically for functional protein design.